表紙
市場調査レポート

院内感染性肺炎(HAP):世界の治験レビュー

Hospital Acquired Pneumonia (HAP) Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 321706
出版日 ページ情報 英文 83 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
院内感染性肺炎(HAP):世界の治験レビュー Hospital Acquired Pneumonia (HAP) Global Clinical Trials Review, H2, 2014
出版日: 2014年12月22日 ページ情報: 英文 83 Pages
概要

当レポートでは、院内感染性肺炎(HAP)の臨床試験に関連する基本情報やデータを提供しており、試験件数および被験者の募集状況、段階別の動向、臨床試験を実施している主な製薬企業および研究機関のプロファイルなどをまとめています。

イントロダクション

  • 院内感染性肺炎(HAP)
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要5カ国における治験件数
    • 中南米の主要5カ国における治験件数

G7諸国での治験件数:感染症の治験における院内感染性肺炎(HAP)の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:感染症の治験における院内感染性肺炎(HAP)の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

院内感染性肺炎(HAP)治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • AstraZeneca PLC
    • Cubist Pharmaceuticals, Inc.
    • Pfizer Inc.
    • Johnson & Johnson
    • Evolva Holding SA
    • Sanofi
    • KaloBios Pharmaceuticals, Inc.
    • Merck & Co., Inc.
    • Janssen Pharmaceuticals, Inc.
    • Basilea Pharmaceutica AG
  • 代表的な研究機関・病院の治験の概要
    • University of Thessaly
    • Prince of Songkla University
    • Universite Victor Segalen Bordeaux 2
    • University of Athens
    • Denver Health and Hospital Authority
    • St. Joseph's Hospital and Medical Center
    • Mahidol University
    • Arak University of Medical Sciences
    • Hospital Pablo Tobon Uribe
    • Hamedan University of Medical Sciences

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2484CTIDB

GlobalData's clinical trial report, "Hospital Acquired Pneumonia (HAP) Global Clinical Trials Review, H2, 2014" provides data on the Hospital Acquired Pneumonia (HAP) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hospital Acquired Pneumonia (HAP). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hospital Acquired Pneumonia (HAP). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Hospital Acquired Pneumonia (HAP)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Hospital Acquired Pneumonia (HAP) to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Hospital Acquired Pneumonia (HAP) to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Hospital Acquired Pneumonia (HAP)
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Cubist Pharmaceuticals, Inc.
      • Clinical Trial Overview of Cubist Pharmaceuticals, Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Evolva Holding SA
      • Clinical Trial Overview of Evolva Holding SA
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • KaloBios Pharmaceuticals, Inc.
      • Clinical Trial Overview of KaloBios Pharmaceuticals, Inc.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Janssen Pharmaceuticals, Inc.
      • Clinical Trial Overview of Janssen Pharmaceuticals, Inc.
      • Basilea Pharmaceutica AG
      • Clinical Trial Overview of Basilea Pharmaceutica AG
    • Clinical Trial Overview of Top Institutes / Government
      • University of Thessaly
      • Clinical Trial Overview of University of Thessaly
      • Prince of Songkla University
      • Clinical Trial Overview of Prince of Songkla University
      • Universite Victor Segalen Bordeaux 2
      • Clinical Trial Overview of Universite Victor Segalen Bordeaux 2
      • University of Athens
      • Clinical Trial Overview of University of Athens
      • Denver Health and Hospital Authority
      • Clinical Trial Overview of Denver Health and Hospital Authority
      • St. Joseph's Hospital and Medical Center
      • Clinical Trial Overview of St. Joseph's Hospital and Medical Center
      • Mahidol University
      • Clinical Trial Overview of Mahidol University
      • Arak University of Medical Sciences
      • Clinical Trial Overview of Arak University of Medical Sciences
      • Hospital Pablo Tobon Uribe
      • Clinical Trial Overview of Hospital Pablo Tobon Uribe
      • Hamedan University of Medical Sciences
      • Clinical Trial Overview of Hamedan University of Medical Sciences
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials by Region, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Hospital Acquired Pneumonia (HAP) to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Hospital Acquired Pneumonia (HAP) to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Hospital Acquired Pneumonia (HAP) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cubist Pharmaceuticals, Inc., 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Evolva Holding SA, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by KaloBios Pharmaceuticals, Inc., 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Pharmaceuticals, Inc., 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Basilea Pharmaceutica AG, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Thessaly, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Prince of Songkla University, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Universite Victor Segalen Bordeaux 2, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Athens, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Denver Health and Hospital Authority, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Joseph's Hospital and Medical Center, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mahidol University, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Arak University of Medical Sciences, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Pablo Tobon Uribe, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamedan University of Medical Sciences, 2014*

List of Figures

  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Hospital Acquired Pneumonia (HAP) to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Hospital Acquired Pneumonia (HAP) to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Hospital Acquired Pneumonia (HAP) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top